Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Bio-Rad Laboratories (BIO)

Bio-Rad Laboratories (BIO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 17,932,900
  • Shares Outstanding, K 29,831
  • Annual Sales, $ 2,312 M
  • Annual Income, $ 1,759 M
  • 60-Month Beta 0.83
  • Price/Sales 7.62
  • Price/Cash Flow 83.30
  • Price/Book 2.00
Trade BIO with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/20
See More
  • Average Estimate 3.10
  • Number of Estimates 1
  • High Estimate 3.10
  • Low Estimate 3.10
  • Prior Year 2.32
  • Growth Rate Est. (year over year) +33.62%

Price Performance

See More
Period Period Low Period High Performance
1-Month
560.97 +7.16%
on 01/04/21
636.97 -5.62%
on 01/07/21
+13.24 (+2.25%)
since 12/15/20
3-Month
507.22 +18.52%
on 11/24/20
648.39 -7.29%
on 11/09/20
+48.54 (+8.78%)
since 10/15/20
52-Week
309.38 +94.31%
on 03/23/20
648.39 -7.29%
on 11/09/20
+224.72 (+59.70%)
since 01/15/20

Most Recent Stories

More News
Bio-Rad to Participate in Fireside Chat at the 39th Annual J.P. Morgan Healthcare Conference on January 11

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that Norman Schwartz, President and CEO; Andrew Last, Executive...

JPM : 138.64 (-1.79%)
BIO : 601.15 (+1.35%)
Should First Trust Capital Strength ETF (FTCS) Be on Your Investing Radar?

Style Box ETF report for FTCS

FTCS : 67.32 (-0.01%)
GRMN : 121.01 (+0.11%)
SPY : 375.70 (-0.73%)
BIO : 601.15 (+1.35%)
GOOGL : 1,727.62 (-0.19%)
IVV : 377.10 (-0.72%)
NEOGEN (NEOG) Q2 Earnings and Revenues Fall Shy of Estimates

NEOGEN's (NEOG) segmental revenues improve for fiscal second quarter on strong sales of cleaners and disinfectants.

DGX : 124.39 (-0.46%)
HOLX : 76.10 (-0.50%)
NEOG : 83.56 (unch)
BIO : 601.15 (+1.35%)
Agios (AGIO) to Sell Oncology Drugs to Servier for $2B, Stock Up

Agios (AGIO) sells its oncology business unit to French company Servier for around $2 billion. The company plans to solely focus on developing treatments for genetically defined diseases. Shares rise.

OMI : 27.69 (+2.03%)
BIO : 601.15 (+1.35%)
LMAT : 42.69 (-1.34%)
AGIO : 45.67 (-0.61%)
Watch for Bio-Rad Labs-A to Potentially Pullback After Gaining 1.57% Yesterday

Bio-Rad Labs-A (NYSE:BIO) traded in a range yesterday that spanned from a low of $554.15 to a high of $566.56. Yesterday, the shares gained 1.6%, which took the trading range above the 3-day high of...

BIO : 601.15 (+1.35%)
SmarTrend Watching for Potential Pullback in Shares of Bio-Rad Labs-A After 1.57% Gain

Bio-Rad Labs-A (NYSE:BIO) traded in a range yesterday that spanned from a low of $554.15 to a high of $566.56. Yesterday, the shares gained 1.6%, which took the trading range above the 3-day high of...

BIO : 601.15 (+1.35%)
Should First Trust Capital Strength ETF (FTCS) Be on Your Investing Radar?

Style Box ETF report for FTCS

FTCS : 67.32 (-0.01%)
GRMN : 121.01 (+0.11%)
SPY : 375.70 (-0.73%)
BIO : 601.15 (+1.35%)
GOOGL : 1,727.62 (-0.19%)
IVV : 377.10 (-0.72%)
Bio-Rad Provides Outlook Through 2023

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, announced today its outlook through 2023, which shows the company's commitment...

BIO : 601.15 (+1.35%)
HealthEquity (HQY) Q3 Earnings and Revenues Beat Estimates

HealthEquity (HQY) delivers strong growth in Service, Custodial and Interchange segments in Q3.

ALGN : 567.23 (+2.27%)
TMO : 503.14 (+1.25%)
BIO : 601.15 (+1.35%)
HQY : 76.61 (-1.91%)
Cooper Companies (COO) Q4 Earnings & Revenues Top Estimates

Cooper Companies' (COO) fiscal fourth-quarter earnings reflect weak segmental performance. However, it exceeds expectation as it witnesses faster-than-anticipated recovery.

COO : 376.89 (+0.46%)
ALGN : 567.23 (+2.27%)
TMO : 503.14 (+1.25%)
BIO : 601.15 (+1.35%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Bio-Rad Laboratories, Inc., together with its subsidiaries, engages in the manufacture and supply of products and systems for the life science research, healthcare, analytical chemistry, and other markets worldwide. The company's products are used to separate complex chemical and biological materials,...

See More

Key Turning Points

3rd Resistance Point 625.11
2nd Resistance Point 615.80
1st Resistance Point 608.47
Last Price 601.15
1st Support Level 591.83
2nd Support Level 582.52
3rd Support Level 575.19

See More

52-Week High 648.39
Last Price 601.15
Fibonacci 61.8% 518.89
Fibonacci 50% 478.89
Fibonacci 38.2% 438.88
52-Week Low 309.38

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar